Arrowpoint Investment Partners (Singapore) Pte. Ltd. Novartis Ag Transaction History
Arrowpoint Investment Partners (Singapore) Pte. Ltd.
- $113 Billion
- Q2 2025
A detailed history of Arrowpoint Investment Partners (Singapore) Pte. Ltd. transactions in Novartis Ag stock. As of the latest transaction made, Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds 3,600 shares of NVS stock, worth $472,824. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,600Holding current value
$472,824% of portfolio
0.05%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
Others Institutions Holding NVS
# of Institutions
1,568Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.4 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.37 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.19 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$993 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$935 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...